Skip to main content

Find Clinical Trials

Home
Conditions
Nevi and Melanomas

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,363 public trials 405 recruiting studies

Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Not Yet Recruiting

A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients

NCT07068074

Conditions: Cutaneous Melanoma, Melanoma, Neoplasms, +10 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Not Yet Recruiting

Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma

NCT07183852

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study of Melanoma-Resistant PET Monitoring Based on Key Rate-limiting Enzymes for Fatty Acid Metabolism in Healthy Volunteers

NCT07114172

Conditions: Health Volunteers, Melanoma, Melanoma (Skin Cancer), +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Testing the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of Melanoma

NCT07040280

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Not Yet Recruiting

Assessment of Safety and Efficacy of OPM-101 Combined With Anti-PD-1 in Patients With Advanced Melanoma Showing Resistance to Anti-PD-1

NCT07040436

Conditions: Advanced Melanoma, Melanoma, Neoplasms, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Evaluate the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocyte in Patients With Refractory Melanoma Who Failed to Immune Checkpoint Inhibitors

NCT07028008

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without Immunotherapy

NCT06976021

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +37 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation

NCT05275374

Conditions: BRAF V600 Mutation, Bronchial Neoplasms, Cancer, +36 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Single-Center Trial on Ketogenic Diet and Immunotherapy in Advanced Cancer This Study Evaluates the Safety and Effects of a Ketogenic Diet (KD) Combined With Immunotherapy in Adults With Advanced Melanoma, cSCC, or RCC.

NCT06896552

Conditions: Adenocarcinoma, Cancer, Carcinoma, +25 more
Locations: Rabin Medical Center Petah Tikva, Israel

View Trial Details

Not Yet Recruiting

A Phase I/ II Study of Fragmented Autoantigen Stimulated T-cell-immunotherapy Combined with Radiotherapy (FAST-CR)

NCT06756295

Conditions: Breast Cancer, Colorectal Cancer, Breast Diseases, Breast Neoplasms, +27 more
Locations: Not specified

View Trial Details